written on 09.05.2014

Pfizer's move on AstraZeneca outrages pols on two continents


Pfizer has managed to upset just about everybody with its $106 billion takeover offer for U.K.-based AstraZeneca. AstraZeneca doesn't like it. The U.K. Parliament is concerned about possible losses of job and status. Some U.S. politicians see it as a tax dodge, and even a couple of governors fear Pfizer will slash AstraZeneca jobs in their states.